Zhaoyan New Drug (603127) Releases Comment: Acquisition of American Security Evaluation Advantage Company BIOMERE: Growth Ceiling

Zhaoyan New Drug 杭州桑拿 (603127) Releases Comment: Acquisition of American Security Evaluation Advantage Company BIOMERE: Growth Ceiling Events: 1) The company announced that it plans to acquire 100% equity of Biomere for US $ 27.28 million; 2) The company announced that it intends to invest 5.5 million yuan in cooperation with Huang Wenjuan, a natural […]

Continue Reading

Yanjinpuzi (002847): Dali sailing from small category to large category bulk weighing

Yanjinpuzi (002847): “Dali” sailing from small category to large category bulk weighing The “Dali” in the field of bulk weighing has for the first time covered a company with a “Buy” rating. The company is the only company in China that has realized multi-category and multi-brand casual small food brands.  The company’s ability to build explosives […]

Continue Reading

Gloria British (002821) quarterly report comments: Q3 in line with expectations rapid growth continued to deliver

Gloria British (002821) quarterly report comments: Q3 in line 北京桑拿洗浴保健 with expectations rapid growth continued to deliver Key points of investment: (1) The company released the 2019 third quarter report: the first three quarters achieved revenue of 17. 4.2 billion (+44. 61%), achieving net attributable profits3. 6.7 billion (+40. 48%), net profit after deduction is […]

Continue Reading

Vanke A (000002) December 2019 sales data review: The long-term sales of stable equity will soon be debated

Vanke A (000002) December 2019 sales data review: The long-term sales of stable equity will soon be debated Event: Vanke announced the company’s sales data for December, and the company achieved a contracted amount of 573 in December. 1 ‰, a year-on-year decrease of 9%; the contracted area reached 414. 80,000 square meters, down 5 […]

Continue Reading